Paul Ehrlich's magic bullets - PubMed

• PMID: 15014180
• DOI: 10.1056/NEJMp048021

Paul Ehrlich's magic bullets

Robert S Schwartz. N Engl J Med. 2004.

Similar articles

• [Ehrlich and the "magic bullet" concept].

  Calvo A. Calvo A. Rev Esp Quimioter. 2006 Mar;19(1):90-2. Rev Esp Quimioter. 2006. PMID: 16688302 Spanish. No abstract available.

• [With magic bullets against syphilis: Paul Ehrlich (1845-1915) and "Salvarsan"].

  Sauerteig L. Sauerteig L. Praxis (Bern 1994). 1999 Oct 28;88(44):1842-4. Praxis (Bern 1994). 1999. PMID: 10584554 German. No abstract available.

• Paul Ehrlich: pioneer of chemotherapy and cure by arsenic (1854-1915).

  Thorburn AL. Thorburn AL. Br J Vener Dis. 1983 Dec;59(6):404-5. doi: 10.1136/sti.59.6.404. Br J Vener Dis. 1983. PMID: 6196079 Free PMC article.

• [100 years of Dr. Ehrlich's magic bullet (1909-2009)].

  García-Sánchez JE, García E, Merino ML. García-Sánchez JE, et al. Enferm Infecc Microbiol Clin. 2010 Oct;28(8):521-33. doi: 10.1016/j.eimc.2009.07.009. Epub 2010 Jan 25. Enferm Infecc Microbiol Clin. 2010. PMID: 20097455 Review. Spanish.

• [Evolution of treatment of syphilis through history].

  Ros-Vivancos C, González-Hernández M, Navarro-Gracia JF, Sánchez-Payá J, González-Torga A, Portilla-Sogorb J. Ros-Vivancos C, et al. Rev Esp Quimioter. 2018 Dec;31(6):485-492. Epub 2018 Nov 14. Rev Esp Quimioter. 2018. PMID: 30427145 Free PMC article. Review. Spanish.

Cited by

• Discovery of VIP236, an αvβ3-Targeted Small-Molecule-Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors.

  Lerchen HG, Stelte-Ludwig B, Heroult M, Zubov D, Gericke KM, Wong H, Frigault MM, Johnson AJ, Izumi R, Hamdy A. Lerchen HG, et al. Cancers (Basel). 2023 Sep 1;15(17):4381. doi: 10.3390/cancers15174381. Cancers (Basel). 2023. PMID: 37686656 Free PMC article.

• Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.

  Kyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A. Kyriakidis I, et al. J Fungi (Basel). 2021 Mar 5;7(3):186. doi: 10.3390/jof7030186. J Fungi (Basel). 2021. PMID: 33807678 Free PMC article. Review.

• Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer.

  Polten R, Kutle I, Hachenberg J, Klapdor R, Morgan M, Schambach A. Polten R, et al. Cancers (Basel). 2022 Dec 30;15(1):263. doi: 10.3390/cancers15010263. Cancers (Basel). 2022. PMID: 36612258 Free PMC article.

• The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.

  Bosch F, Rosich L. Bosch F, et al. Pharmacology. 2008;82(3):171-9. doi: 10.1159/000149583. Epub 2008 Aug 5. Pharmacology. 2008. PMID: 18679046 Free PMC article. Review.

• Personalized Medicine in Allergy.

  Ferrando M, Bagnasco D, Varricchi G, Bernardi S, Bragantini A, Passalacqua G, Canonica GW. Ferrando M, et al. Allergy Asthma Immunol Res. 2017 Jan;9(1):15-24. doi: 10.4168/aair.2017.9.1.15. Allergy Asthma Immunol Res. 2017. PMID: 27826958 Free PMC article. Review.

Publication types

MeSH terms

Substances

Personal name as subject

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.